Galmed Pharmaceuticals Ltd. (GLMD)
Market Closed
11 Aug, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 56
-0.04
-6.1035%
After Hours
$
+0.04 +6.5003% 0. 59
4.97M Market Cap
- P/E Ratio
- Div Yield
29,516 Volume
-1.29 Eps
$ 0.59
Previous Close Investors:
Want to track GLMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Galmed Pharmaceuticals Ltd. (GLMD) Statistics
Valuation metrics
Market Cap 4.97M
Enterprise value 3.37M
Trailing P/E (ttm) -0.3
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 0.28
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.3
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 60.71K
Average volume (90 days) 787.22K
Price summary
52-Week low 0.41
52-Week high 1.65
Beta -
50-Day moving average 0.59
200-Day moving average 0.63
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:12
Last split Date 30 Aug 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.69%
Return on equity -0.64%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.69
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.34
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 7.71%
Book value per share (mrq) 2.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
